London. 10 September 2013. Norgine Ventures today announced that it has provided debt financing of £2 million to Internis Pharmaceuticals. This funding recognises the potential of Internis, an exciting and innovative British start-up company. Norgine Ventures is a business entity of Norgine, a well-established independent pan-European pharmaceutical company. Norgine Ventures’ backing will enable Internis to […]